NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Tuesday that its third quarter revenues grew 8 percent year over year, thanks largely to 9 percent growth for its Diagnostics and Genomics group.

For the three months ended July 31, the life sciences company said total revenues rose to $1.20 billion from $1.11 billion in Q3 2017, in line with analysts' average estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.